Jun 25 |
Rigel announces reverse stock split
|
Jun 25 |
Rigel Announces Reverse Stock Split
|
Jun 24 |
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application
|
Jun 14 |
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
|
Jun 3 |
Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting
|
May 30 |
Rigel to Present at the Jefferies Global Healthcare Conference
|
May 23 |
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
|
May 10 |
Rigel (RIGL) Upgraded to Buy: Here's What You Should Know
|
May 10 |
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results
|
May 8 |
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
|